Regenerative Medicine Research

Building solutions for cardiovascular repair & regeneration.

Texas Heart Institute (THI) is a leader in cardiovascular research including one of the most promising areas of medicine today, Regenerative Medicine. To lead the world in creating, translating, and delivering novel solutions for cardiovascular repair and regeneration, THI launched the Regenerative Medicine Research Department (RMR) in 2012.

The RMR team is a multi-cultural, diverse group of scientists, researchers and experts who utilize their depth of knowledge and unique backgrounds to contribute to the department’s areas of translational research.

Our Department

Current Projects Our Services

“The workings of the human heart are the profoundest mystery of the universe.” Charles W. Chestnutt, 1858-1899

Building the future treatments of tomorrow.

Our Regenerative Medicine Research department is dedicated to unveiling the next discovery in this promising, emerging field. Primarily, the team is focused on furthering the science of engineering bio-artificial organs and tissues, understanding aging as a failure of stem cells, and identifying sex differences in cardiovascular disease and regenerative medicine treatments.

FAQ Biorepository & Biospecimen Profiling Core Lab

Our Team

The RMR team is a multi-cultural, diverse group of scientists, researchers and experts who utilize their depth of knowledge and unique backgrounds to contribute to the department’s areas of translational research.

Current Projects

The RMR consists of two laboratories – the Biorepository & Sample Profiling Core Laboratory (BPL) and the Organ Repair & Regeneration Research Laboratory (OR3). Learn more about the progress our team is making to further the science of engineering bio-artificial organs and tissues, understand aging as a failure of stem cells and identify sex differences in cardiovascular disease and regenerative medicine treatments.

Recent News

As a leading international regenerative medicine research program we are exploring creating cutting edge therapies for chronic disease and “building the future treatments of tomorrow.